Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-07-19
1992-11-10
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 43, C07D22122
Patent
active
051623315
ABSTRACT:
A tetrahydroquinoline alkaloid compound named "aspernomine" has been isolated from the sclerotia of the fungus Aspergillus nomius. Aspernomine has the structure: ##STR1## and is effective for controlling Lepidopteran insects.
REFERENCES:
patent: 5017598 (1991-05-01), Dowd et al.
Gloer et al. "Nominine: A New Insecticidal Indole Diterpene from the Sclerotia of Aspergillus nomius". J. Org. Chem, vol. 54, 1989, pp. 2530-2532.
Kurztman et al. "Aspergillus nomius, A New Aflatoxin-Producing Species Related to Aspergillus flavus and Aspergillus tamarii.", Antonie Van Leeuwenhoek, vol. 53, 1987, pp. 147-158.
Dowd Patrick F.
Gloer James B.
Staub Gail M.
Wicklow Donald T.
Biotechnology Research & Development Corporation
Daus Donald G.
The United States of America as represented by the Secretary of
University of Iowa Research Foundation
LandOfFree
Aspernomine, an antiinsectan metabolite does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aspernomine, an antiinsectan metabolite, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aspernomine, an antiinsectan metabolite will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2292931